NCT00545454 - Activity and Safety of Oral Administration of SSR150106XB for the Reduction of Inflammation in Patients With Active Rheumatoid Arthritis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions

Rheumatoid Arthritis

Interventions

DRUG

SSR150106

DRUG

Placebos

Trial Locations (7)

Sanofi-Aventis Administrative Office, Sofia

Sanofi-Aventis Administrative Office, Zagreb

Sanofi-Aventis Administrative Office, Prague

Sanofi-Aventis Administrative Office, Bucharest

Sanofi-Aventis Administrative Office, Moscow

Sanofi-Aventis Administrative Office, Bratislava

Sanofi-Aventis Administrative Office, Kiev